OBD — Oxford Biodynamics Cashflow Statement
0.000.00%
Last trade - 00:00
- £14.31m
- £19.13m
- £0.51m
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -3.39 | -4.91 | -7.63 | -7.57 | -11.4 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | -0.022 | 0.236 | 0.245 | -0.778 | 1.62 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0.75 | 0.806 | 0.378 | 1.96 | 0.143 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Payable / Accrued Expenses | |||||
Change in Taxes Payable | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -2.27 | -3.4 | -5.92 | -5.18 | -8.29 |
Capital Expenditures | -0.632 | -0.457 | -3.09 | -0.901 | -0.716 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -10.6 | 5.04 | 5.92 | 2.15 | 0.096 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -11.2 | 4.58 | 2.83 | 1.25 | -0.62 |
Financing Cash Flow Items | 0 | — | — | -0.358 | -1.46 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0.236 | -0.181 | -0.804 | 2.56 | 13.2 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -13.1 | 0.921 | -3.94 | -1.2 | 4.28 |